Fennec Pharma
Fennec Pharma
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS) | Ear Diseases, Genital Diseases, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasms by Site, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, gonadal disorder, head and neck cancer, hearing disorder, hearing loss disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, neoplasm, nervous system disorder, otorhinolaryngologic disease, testicular cancer, testicular disorder, thoracic cancer | Recruiting | Phase 1 / Phase 2 | 2026-06-18 | NCT07407582 |